Holy shit, #Ozempic is expensive in Canada , $505.59 for my first set of doses . Yay for insurance but still ..how much is it in the states?
#Wegovy
Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’
https://www.independent.co.uk/news/health/ozempic-drug-semaglutide-lawsuit-blindness-b2754728.html
Novo Nordisk's sudden CEO change shocks market, raising questions about company's future amid fierce competition and recent stock price decline
#YonhapInfomax #NovoNordisk #CEOChange #Wegovy #MarketShare #PharmaceuticalIndustry #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=64037
Ozempic und Wegovy: Mehr gefälschte Rezepte für Abnehmspritzen
Abnehmspritzen sind zu regelrechten Lifestyle-Produkten geworden. Der Hype um Produkte wie Ozempic und der hohe Preis rufen auch Kriminelle auf den Plan, die gefälschte Rezepte verkaufen.
#Abnehmspritzen #Wegovy #Ozempic #Rezept #Fälschungen #Apotheke #Medikament #Kriminalität
[These are miracle drugs with so many benefits. Insurance should be forced to cover them or they should be nationalized for the sake of the world's health, not just for the rich.]
Experts say rather than being an acute treatment, as would be used for something like an infection, these medications should be viewed as a treatment for a chronic condition, similar to the way statins are used.
#GLP1 #Ozempic #Wegovy #Mounjaro #Trulicity #Semaglutide #Tirzepatide #Dulaglutide
https://www.theguardian.com/news/ng-interactive/2025/may/17/weight-loss-drugs-altering-views-how-body-brain-work
Новина: Novo Nordisk оголосила про зміну генерального директора. Рішення пов'язане з посиленням конкуренції на ринку препаратів для схуднення (#Ozempic, #Wegovy). Деталі та причини змін. #NovoNordisk #Фармацевтика #Здоров'я #Ожиріння #Бізнес
Детальніше: https://newsua.us/node/6897
'People who stop weight loss drugs return to original weight within year, analysis finds'
"Analysis of 11 studies of older and newer GLP-1 weight loss drugs by the University of Oxford found that patients typically lost 8kg on weight loss jabs but returned to their original weight within 10 months of stopping them."
"The study, presented at the European Congress on Obesity, found that even for those taking newer, higher-dose weight loss drugs such as Wegovy and Mounjaro, people put weight back on once they stopped treatment."
"The findings raise issues for the NHS, as Nice guidelines state people should not be on weight loss injections for more than two years. Additionally, many patients give up the treatment, whether because they are buying it privately so cannot afford it, because the side-effects do not suit them or because they are not losing weight any more."
“We need to ensure patients have the support to make the changes in their behaviour they need to sustain the benefits of treatment. [Weight loss jabs] are an adjunct to behavioural change, not a replacement.”
Zepbound beats Wegovy rival in 1st head-to-head weight loss study
People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50 per cent more weight than those using rival Novo Nordisk's Wegovy.
#health #medicine #weightloss #glp1receptoragonists #Wegovy #Zepbound
https://globalnews.ca/news/11175237/zepbound-outperforms-wegovy-weight-loss-trial/
#Evidence that #tirzepatide (#Munjaro) causes more pronounced #weightloss than #semaglutide (#Wegovy, #Ozempic, #Rybelsus). Notably, the trial was funded by the pharma company behind tirzepatide.
Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs
“The point of these medications is to improve health,” he said. “The majority of people won’t need the most effective medication.”
Will #insurance companies share the savings by reducing premiums as net costs for #healthcare decline, after factoring in #GLP1 costs?
#diabetes #wegovy #ozempic #mounjaro #zepbound #semaglutide #tirzepatide
www.cnbc.com/2025/04/30/g...
GLP-1s can help employers lowe...
Stark abgenommen mit #Ozempic, #Wegovy und Co.? Mit den neuen Abnehmmitteln #Semaglutid und #Tirzepatid verlieren viele Patient:innen schnell an #Gewicht. Wer regelmäßig weitere #Medikamente nimmt, braucht dann bei manchen eine Anpassung der #Dosis. (€)
https://gutepillen-schlechtepillen.de/stark-abgenommen-mit-ozempic-wegovy-und-co/
New Review and Meta-Analysis confirms weight gain with discontinuance of #Semaglutide and #Tirzepatide
Discontinuing GLP1 medications led to a pooled overall mean weight regain of 9.69 kg (or about 22 lbs in patients prescribed semaglutide/tirzepatide. The proportion of weight regained was proportional to the amount originally lost.
Discontinuation of GLP-1RA treatment leads to weight regain, regardless of lifestyle interventions, and should therefore be considered a chronic therapy to prevent weight regain and associated undesirable outcomes related to #Obesity.
#wegovy #ozempic #mounjaro #zepbound
https://onlinelibrary.wiley.com/doi/10.1111/obr.13929
Nach 50% Kursrückgang scheint die Bewertung dieses Wachstumstitels jetzt wieder fair
Es kommt mir schon vor wie eine Reise in die weite Vergangenheit: zuletzt habe ich über diese Aktie vor acht Monaten berichtet. Da gab es die Zwischendividende für das laufende Geschäftsjahr und ich titelte, dass sich der Aktienkurs zwar auf hohem Niveau hielte, aber neue Impulse fehlen würden. Tja, das sah dann die Börse wohl auch so: mangels neuer Impulse gab es eine Neubewertung, die es in sich hat: die Aktie hat sich in diesem überschaubaren Zeitraum mehr als halbiert. Und das noch vor der Korrektur in diesen Tagen. Der Depotanteil ist dadurch von 7,4% auf 3,5% zurückgegangen. Und aus einem vorherigen Top-3-Depotwert ist nur noch ein Mitläufer auf Platz 8 geworden. Warum mich das trotzdem weitgehend entspannt lässt und ich von der Qualität des Unternehmens unverändert überzeugt bin, erfährst Du in diesem Beitrag. […]
El auge de Ozempic y Wegovy altera los hábitos de consumo de alcohol https://www.vinetur.com/2025040286276/ozempic-and-wegovy-alter-alcohol-consumption-trends.html?utm_source=dlvr.it&utm_medium=mastodon #Ozempic #Wegovy #salud #bienestar #consumoresponsable
GLP-1s Are Crazy Effective — Just Not Cost-Effective
I’ll make the argument that the most effective drugs in the past decade are the GLP-1 receptor agonists, drugs like semaglutide and tirzepatide. At least in terms of weight loss, they are truly unparalleled. They are clearly effective. But are they worth it? Are they cost-effective? That is a much harder question, and, as you’ll see in a minute, despite their amazing effects, the answer — for now, at least — is no.
#mounjaro #ozempic #zepbound #wegovy #glp1
https://www.medscape.com/viewarticle/glp-1s-are-crazy-effective-just-not-cost-effective-2025a10006es?form=fpf
Client Info
Server: https://mastodon.social
Version: 2025.04
Repository: https://github.com/cyevgeniy/lmst